Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-12 10:35 am Unchanged | 13G | MYOMO INC. MYO | Rosalind Advisors Inc. | 4,575,385 9.9% | 0 (Unchanged) | View |
| 2024-07-11 6:02 pm Unchanged | 13G | MYOMO INC. MYO | Rosalind Advisors Inc. | 4,575,385 9.9% | 0 (Unchanged) | View |
| 2024-07-11 5:52 pm Purchase | 13G | Trevi Therapeutics Inc. TRVI | Rosalind Advisors Inc. | 1,391,577 1.98% | 465,561 (+50.28%) | View |
| 2024-07-11 5:48 pm Sale | 13G | InspireMD Inc. NSPR | Rosalind Advisors Inc. | 7,438,181 9.9% | -21,747 (-0.29%) | View |
| 2024-07-11 5:43 pm Purchase | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 513,490 7.16% | 27,500 (+5.66%) | View |
| 2024-07-11 5:37 pm Unchanged | 13G | Cellectar Biosciences Inc. CLRB | Rosalind Advisors Inc. | 3,992,586 9.9% | 0 (Unchanged) | View |
| 2024-05-29 3:47 pm Unchanged | 13G | KIORA PHARMACEUTICALS INC KPRX | Rosalind Advisors Inc. | 4,182,094 9.9% | 0 (Unchanged) | View |
| 2024-05-29 3:43 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Rosalind Advisors Inc. | 4,182,094 9.9% | 4,182,094 (New Position) | View |
| 2024-05-29 3:32 pm Purchase | 13G | OptiNose Inc. OPTN | Rosalind Advisors Inc. | 7,547,148 7.75% | 3,005,659 (+66.18%) | View |
| 2024-05-29 3:21 pm Purchase | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 7,872,489 9.9% | 7,368,228 (+1461.19%) | View |
| 2024-05-17 12:58 pm Sale | 13G | InspireMD Inc. NSPR | Rosalind Advisors Inc. | 7,459,928 9.9% | -1,528,390 (-17.00%) | View |
| 2024-05-17 12:48 pm Sale | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,763,468 9.9% | -188,734 (-6.39%) | View |
| 2024-04-25 8:01 pm Sale | 13G | Cellectar Biosciences Inc. CLRB | Rosalind Advisors Inc. | 3,992,586 9.9% | -2,684,347 (-40.20%) | View |
| 2024-04-25 7:39 pm Sale | 13G | Trevi Therapeutics Inc. TRVI | Rosalind Advisors Inc. | 926,016 1.34% | -1,573,977 (-62.96%) | View |
| 2024-04-25 7:30 pm Unchanged | 13G | InspireMD Inc. NSPR | Rosalind Advisors Inc. | 8,988,318 9.9% | 0 (Unchanged) | View |
| 2024-04-25 7:22 pm Purchase | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 485,990 6.92% | 6,000 (+1.25%) | View |
| 2024-04-25 7:13 pm Unchanged | 13G | MYOMO INC. MYO | Rosalind Advisors Inc. | 4,575,385 9.9% | 0 (Unchanged) | View |
| 2024-04-25 7:01 pm Sale | 13G | OptiNose Inc. OPTN | Rosalind Advisors Inc. | 4,541,489 5.14% | -344,091 (-7.04%) | View |
| 2024-04-25 6:52 pm Sale | 13G | SPRUCE BIOSCIENCES INC SPRB | Rosalind Advisors Inc. | 1,508,419 3.67% | -813,581 (-35.04%) | View |
| 2024-03-25 6:55 pm Purchase | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,952,202 9.9% | 541,678 (+22.47%) | View |